Solara Active Pharma Sciences Limited (SOLARA) — Announcement | 23 June 2026

StockFin.ai

Try Free

Solara Active Pharma Sciences Limited announced a credit rating upgrade from Crisil Ratings for its Rs.791.2 crore bank loan facilities, elevating the long-term rating to Crisil BBB+/Stable and short-term to Crisil A2. The upgrade reflects improved creditworthiness and strengthens investor confidence in the company's financial stability. The rating letter is valid until March 31, 2027, and the company must seek revalidation if facilities are not drawn within 180 days.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SOLARA ✨ Ask AI About This

About Solara Active Pharma Sciences Limited (SOLARA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹2,097.66 Cr P/E: -8.3

View full SOLARA stock details →

📡 Get AI alerts when SOLARA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SOLARA — Free

💡 Ask AI about this filing

"How does this announcement affect Solara Active Pharma Sciences Limited's outlook?" "What did Solara Active Pharma Sciences Limited announce on 23 June 2026?" "Is this positive or negative for SOLARA?"

Ask AI Free →

📊 More SOLARA filings

See all SOLARA filings →

🔥 Also filed on 23 June 2026

RAYMONDREL Raymond Realty Limited Annual Report PRAXIS Praxis Home Retail Limited Financial Results PREMIER Premier Limited Financial Results RAYMONDLSL Raymond Lifestyle Limited Annual Report RAYMOND Raymond Limited Annual Report REPCOHOME Repco Home Finance Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when SOLARA files new disclosures

Track SOLARA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SOLARA — Free

Free account · 2 AI queries/day